PCSK9 Plasma Concentrations Are Independent of GFR and Do Not Predict Cardiovascular Events in Patients with Decreased GFR
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PCSK9 Plasma Concentrations Are Independent of GFR and Do Not Predict Cardiovascular Events in Patients with Decreased GFR
Authors
Keywords
Glomerular filtration rate, Statins, Cholesterol, Cardiovascular diseases, Chronic kidney disease, Diabetes mellitus, Blood pressure, Kidneys
Journal
PLoS One
Volume 11, Issue 1, Pages e0146920
Publisher
Public Library of Science (PLoS)
Online
2016-01-23
DOI
10.1371/journal.pone.0146920
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lower Apo A-I and Lower HDL-C Levels Are Associated With Higher Intermediate CD14 ++ CD16 + Monocyte Counts That Predict Cardiovascular Events in Chronic Kidney Disease
- (2014) Kyrill S. Rogacev et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Fibroblast growth factor 23 (FGF23) and mortality: The Ludwigshafen Risk and Cardiovascular Health Study
- (2014) Vincent M. Brandenburg et al. ATHEROSCLEROSIS
- Chronic kidney disease on hemodialysis is associated with decreased serum PCSK9 levels
- (2014) H. Abujrad et al. ATHEROSCLEROSIS
- PCSK9
- (2014) Nabil G. Seidah et al. CIRCULATION RESEARCH
- Associations of FGF-23 and sKlotho with Cardiovascular Outcomes among Patients with CKD Stages 2-4
- (2014) S. Seiler et al. Clinical Journal of the American Society of Nephrology
- Plasma PCSK9 in Nephrotic Syndrome and in Peritoneal Dialysis: A Cross-sectional Study
- (2013) Kyubok Jin et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Targeting the Proprotein Convertase Subtilisin/Kexin Type 9 for the Treatment of Dyslipidemia and Atherosclerosis
- (2013) Daniel Urban et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
- (2013) Ron T Gansevoort et al. LANCET
- Proprotein convertase subtilisin–kexin type 9 is elevated in proteinuric subjects: Relationship with lipoprotein response to antiproteinuric treatment
- (2012) Arjan J. Kwakernaak et al. ATHEROSCLEROSIS
- Cholesterol Synthesis, Cholesterol Absorption, and Mortality in Hemodialysis Patients
- (2012) K. S. Rogacev et al. Clinical Journal of the American Society of Nephrology
- Calcium and phosphate impact cardiovascular risk
- (2012) Gunnar H. Heine et al. EUROPEAN HEART JOURNAL
- Monocyte subpopulations and cardiovascular risk in chronic kidney disease
- (2012) Gunnar H. Heine et al. Nature Reviews Nephrology
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
- (2011) Colin Baigent et al. LANCET
- Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
- (2010) SHARP Collaborative Group AMERICAN HEART JOURNAL
- Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease
- (2010) P. Stenvinkel JOURNAL OF INTERNAL MEDICINE
- Genetic and Metabolic Determinants of Plasma PCSK9 Levels
- (2009) Susan G. Lakoski et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
- (2009) Bengt C. Fellström et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started